Australian TGA approves Glaukos’ PRESERFLO microshunt
PRESERFLO MicroShunt is designed to allow draining of eye fluid and lowering of IOP in primary open-angle glaucoma patients.
Opthalmic
FDA approves J&J Vision’s therapeutic contact lenses for myopia
Johnson & Johnson Vision’s overnight therapeutic lenses receive FDA approval for myopia.
New report paints bright future for contact lens tech
A newly-published paper in Contact Lens and Anterior Eye has reviewed innovative uses for contact...
Contact lenses developed to monitor ocular disease progression
Novel contact lens technology developed at Purdue University may soon be able to help diagnose...
Topcon launches Aladdin-M myopia management system in US
Japan-based ophthalmology medical devices and software solutions provider Topcon Healthcare has launched its new Aladdin-M...
Sight Sciences enrols first patients in OMNI Surgical System trial
Sight Sciences has enrolled first patients in the ORION clinical study that evaluates OMNI Surgical System in patients with mild-to-moderate glaucoma.
Eye on the prize: ophthalmology’s digital future
Artificial intelligence is already being used to monitor diabetic retinopathy while scientists elsewhere have shown machine learning can model to predict visual acuity. Digital technology holds immense promise, but where are the breakthroughs likely to...
3D visualisation tech launched for UK cancer patients
GenesisCare has launched the Brainlab Mixed Reality Viewer at its Oxford centre for diagnostics, oncology and wellbeing, offering cancer patients a novel way to visualise their treatment.
Magseed cleared for long-term lymph node marking in Europe
UK-headquartered seed localisation company Endomag has received an extended indication in Europe for long-term use of its Magseed magnetic marker in any soft tissue to identify suspicious lymph nodes before chemotherapy and surgery.
FDA gives Breakthrough Device designation to EyeYon’s EndoArt
The US Food and Drug Administration (FDA) has granted Breakthrough Status designation to EyeYon Medical’s artificial endothelial layer implant EndoArt.
Assessing ‘stickiness’ of tumour cells could improve cancer prognosis
Researchers at the University of California San Diego have created a microfluidic device which measures how ‘sticky’ cancer cells are and could improve prognostic evaluation of patient tumours.
